Lamivir HVB Information

Manufacturer of Lamivir HBV is Cipla Pharmaceuticals Limited, India.
1 tablet of Lamivir HBV contains 100mg of Lamivudine. This medication is meant for the treatment of chronic hepatitis B associated with evidence of hepatitis B viral replication and active liver inflammation. Normal dose of Lamivir is 1 pill per day, or 100 mg of Lamivudine per day. This medication is very effective and has mild side effects.

LAMIVIR- HBV isn’t suitable for patients infected both with HBV and HIV. If Lamivudine is given to patients like that, the dose must be significantly increased, as indicated for HIV therapy and must be used as part of an appropriate combination regimen. This medication should not be taken without the prescription and strictly indicated dosage.